News & Updates

Statins are effective for primary prevention of cardiovascular disease (CVD) and all-cause mortality in individuals aged 75–84 and ≥85 years, and are not associated with significantly increased risks of myopathies and liver dysfunction, according to a target trial emulation conducted using real-world territory-wide electronic health records in Hong Kong.

Erectile dysfunction (ED) is independently associated with a higher risk of major adverse cardiovascular events (MACE), suggests a study. Moreover, rural men appear to be at greater risk of MACE, with an even higher risk among those with an ED diagnosis.

In the CAST-HF trial, the addition of direct cardiac shockwave therapy (SWT) to coronary artery bypass graft (CABG) surgery improves left ventricular ejection fraction (LVEF) and physical capacity in individuals with ischaemic heart failure (IHF).

In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.

Mobile health (mHealth) technology appears advantageous among adults with a greater number of cardiovascular disease (CVD) risk factors, who use the technology to share information and discuss health-related decisions with their providers, according to a study.